华东医药

- 000963

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2024  2023  2022  2021  2020  2019  2018  2017  2016  2015 
华东医药(000963) 利润表
单位:万元
报表日期2024-09-302024-06-302024-03-312023-12-312023-09-30
一、营业总收入3,147,765.482,096,506.561,041,080.914,062,378.253,039,453.05
营业收入3,147,765.482,096,506.561,041,080.914,062,378.253,039,453.05
二、营业总成本2,828,881.171,887,679.92933,135.753,708,191.512,753,950.52
营业成本2,123,180.341,410,980.36707,639.712,746,173.162,071,143.35
营业税金及附加16,379.2011,100.865,633.4623,259.0315,506.39
销售费用472,751.25327,482.29157,426.19664,541.14466,235.05
管理费用117,902.3271,463.3133,516.92142,018.90110,583.61
财务费用3,801.782,342.44755.505,118.986,403.32
研发费用94,866.2964,310.6628,163.98127,080.3184,078.81
资产减值损失----------
公允价值变动收益-----2.54-1,375.64-661.66
投资收益-8,671.03-4,784.59-4,716.34-21,971.30-16,884.29
其中:对联营企业和合营企业的投资收益-5,456.30-2,525.62-3,750.45-18,839.06-14,531.42
汇兑收益----------
三、营业利润321,535.22208,111.49107,209.58345,292.72270,857.28
加:营业外收入744.27522.20129.565,054.88353.70
减:营业外支出8,891.133,778.43520.263,749.032,400.01
其中:非流动资产处置损失----------
四、利润总额313,388.36204,855.26106,818.88346,598.58268,810.97
减:所得税费用57,127.9336,033.7620,794.3361,958.8849,456.08
五、净利润256,260.43168,821.5186,024.55284,639.69219,354.88
归属于母公司所有者的净利润256,232.67169,602.0686,241.16283,886.05218,904.68
少数股东损益27.76-780.55-216.60753.64450.20
六、每股收益
基本每股收益(元/股)1.46440.96750.49291.62191.2510
稀释每股收益(元/股)1.46390.96860.49281.62071.2503
七、其他综合收益1,767.59-628.554,058.955,050.65-388.90
八、综合收益总额258,028.02168,192.9590,083.51289,690.34218,965.99
归属于母公司所有者的综合收益总额258,000.26168,973.5190,300.11288,936.70218,515.79
归属于少数股东的综合收益总额27.76-780.55-216.60753.64450.20
下载全部历史数据到excel中 返回页顶